Literature DB >> 16710608

Human beta-defensins.

M Pazgier1, D M Hoover, D Yang, W Lu, J Lubkowski.   

Abstract

The last decade led to the discovery and characterization of several human beta-defensins. Analysis of genomic information indicates that the number of beta-defensin-like molecules encoded by the human genome may number in the tens. Growing interest in beta-defensins steadily enhances our knowledge about various aspects of their gene location, expression patterns and the transcription factors involved in their regulation in vivo. The hallmark property of beta-defensins, their antimicrobial activity, is clearly only the tip of the iceberg in the extensive network of inter-relations within the immune system in which these peptides function. Structural studies of beta-defensins provide the molecular basis for a better understanding of their properties, functions and their potential for practical applications. In this review, we present some recent advances in the studies of human beta-defensins, with an emphasis on possible correlations between their structural and functional properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710608     DOI: 10.1007/s00018-005-5540-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  166 in total

1.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 2.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

3.  Functional intersection of Human Defensin 5 with the TNF receptor pathway.

Authors:  Wuyuan Lu; Erik de Leeuw
Journal:  FEBS Lett       Date:  2014-03-26       Impact factor: 4.124

4.  CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.

Authors:  Rebecca A Vongsa; Noah P Zimmerman; Michael B Dwinell
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 5.  Diversity in penaeidin antimicrobial peptide form and function.

Authors:  Brandon J Cuthbertson; Leesa J Deterding; Jason G Williams; Kenneth B Tomer; Kizee Etienne; Perry J Blackshear; Erika E Büllesbach; Paul S Gross
Journal:  Dev Comp Immunol       Date:  2007-08-03       Impact factor: 3.636

6.  Comprehensive defensin assay for saliva.

Authors:  Michael S Gardner; Megan D Rowland; Amy Y Siu; Jonathan L Bundy; Diane K Wagener; James L Stephenson
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

7.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

8.  Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.

Authors:  Jesper S Oeemig; Carina Lynggaard; Daniel H Knudsen; Frederik T Hansen; Kent D Nørgaard; Tanja Schneider; Brian S Vad; Dorthe H Sandvang; Line A Nielsen; Søren Neve; Hans-Henrik Kristensen; Hans-Georg Sahl; Daniel E Otzen; Reinhard Wimmer
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

9.  Increased expression of beta-defensin-2 and -3 during the development of autoimmune sialoadenitis in MRL/lpr mice.

Authors:  Masato Saitoh; Yoshihito Kurashige; Mami Yamazaki; Michiko Nishimura; Sumiko Nakamura; Daisuke Noro; Maiko Takeshima; Toshiya Arakawa; Taishin Takuma; Seiji Igarashi; Tohru Kaku; Takashi Inoue; Yoshihiro Abiko
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

10.  Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.

Authors:  David Moranta; Verónica Regueiro; Catalina March; Enrique Llobet; Javier Margareto; Eider Larrarte; Eider Larrate; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.